Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Consulting And Technology Services | 11,587.0 | 10,182.0 | 9,946.0 | 9,309.0 | | | | |
| Healthcare Segment | 6,920.0 | 6,470.0 | 6,837.0 | 6,816.0 | | | | |
| Financial Services | 6,051.0 | 5,621.0 | 5,869.0 | 5,845.0 | | 5,366.0 | 5,003.0 | 4,286.0 |
| Healthcare | 5,337.0 | 4,852.0 | 4,695.0 | 4,668.0 | | 3,871.0 | 3,668.0 | 2,689.0 |
| Other | | | | | | 4,250.0 | 3,745.0 | 3,288.0 |
| Total revenues | 18,507.0 | 16,652.0 | 16,783.0 | 16,125.0 | 14,810.0 | 13,487.0 | 12,416.0 | 10,263.0 |
| Revenue growth [+] | 11.1% | -0.8% | 4.1% | 8.9% | 9.8% | 8.6% | 21.0% | 16.1% |
| Consulting And Technology Services | 13.8% | 2.4% | 6.8% | | | | | |
| Healthcare Segment | 7.0% | -5.4% | 0.3% | | | | | |
| Financial Services | 7.6% | -4.2% | 0.4% | | | 7.3% | 16.7% | 15.3% |
| Healthcare | 10.0% | 3.3% | 0.6% | | | 5.5% | 36.4% | 18.7% |
| Products and Resources | 15.7% | -2.0% | 10.4% | | | 13.5% | 11.9% | 12.1% |
| Cost of goods sold | 11,604.0 | 10,671.0 | 10,634.0 | 9,838.0 | 9,152.0 | 8,108.0 | 7,440.0 | 6,141.0 |
| Gross profit | 6,903.0 | 5,981.0 | 6,149.0 | 6,287.0 | 5,658.0 | 5,379.0 | 4,976.0 | 4,122.0 |
| Gross margin | 37.3% | 35.9% | 36.6% | 39.0% | 38.2% | 39.9% | 40.1% | 40.2% |
| Selling, general and administrative | 3,503.0 | 3,100.0 | 2,972.0 | 3,007.0 | 2,697.0 | 2,731.0 | 2,509.0 | 2,037.0 |
| Equity in earnings | 3.0 | | -58.0 | 2.0 | 2.0 | 1.0 | | |
| EBITDA [+] | 3,403.0 | 2,888.0 | 3,138.0 | 3,320.0 | 2,998.0 | 2,669.0 | 2,472.0 | 2,093.0 |
| EBITDA growth | 17.8% | -8.0% | -5.5% | 10.7% | 12.3% | 8.0% | 18.1% | 12.7% |
| EBITDA margin | 18.4% | 17.3% | 18.7% | 20.6% | 20.2% | 19.8% | 19.9% | 20.4% |
| Depreciation | 392.0 | 407.0 | 364.0 | 347.0 | 313.0 | 266.0 | 233.0 | 172.0 |
| EBITA | 3,011.0 | 2,481.0 | 2,774.0 | 2,973.0 | 2,685.0 | 2,403.0 | 2,239.0 | 1,921.0 |
| EBITA margin | 16.3% | 14.9% | 16.5% | 18.4% | 18.1% | 17.8% | 18.0% | 18.7% |
| Amortization of intangibles | 182.0 | 152.0 | 162.0 | 151.0 | 130.0 | 113.0 | 97.0 | 36.0 |
| EBIT [+] | 2,829.0 | 2,329.0 | 2,612.0 | 2,822.0 | 2,555.0 | 2,290.0 | 2,142.0 | 1,885.0 |
| EBIT growth | 21.5% | -10.8% | -7.4% | 10.5% | 11.6% | 6.9% | 13.6% | 12.3% |
| EBIT margin | 15.3% | 14.0% | 15.6% | 17.5% | 17.3% | 17.0% | 17.3% | 18.4% |
| Non-recurring items | | 215.0 | 217.0 | 19.0 | 72.0 | | | |
| Interest expense, net [+] | 9.0 | 24.0 | 26.0 | 27.0 | 23.0 | 19.0 | -66.0 | -59.0 |
| Interest expense | 9.0 | 24.0 | 26.0 | 27.0 | 23.0 | 19.0 | 18.0 | 3.0 |
| Interest income | | | | | | | 84.0 | 62.0 |
| Other income (expense), net [+] | 7.0 | 6.0 | 174.0 | 21.0 | 195.0 | 86.0 | -44.0 | -20.0 |
| Gain (loss) on foreign currency transactions | -20.0 | -116.0 | -65.0 | -152.0 | 67.0 | -30.0 | -43.0 | -20.0 |
| Other | | 3.0 | 5.0 | -2.0 | -3.0 | 2.0 | -1.0 | |
| Pre-tax income | 2,827.0 | 2,096.0 | 2,543.0 | 2,797.0 | 2,655.0 | 2,357.0 | 2,164.0 | 1,924.0 |
| Income taxes | 693.0 | 704.0 | 643.0 | 698.0 | 1,153.0 | 805.0 | 540.0 | 485.0 |
| Tax rate | 24.5% | 33.6% | 25.3% | 25.0% | 43.4% | 34.2% | 25.0% | 25.2% |
| Net income | 2,137.0 | 1,392.0 | 1,842.0 | 2,101.0 | 1,504.0 | 1,553.0 | 1,624.0 | 1,439.0 |
| Net margin | 11.5% | 8.4% | 11.0% | 13.0% | 10.2% | 11.5% | 13.1% | 14.0% |
| |
| Basic EPS [+] | $4.06 | $2.58 | $3.30 | $3.61 | $2.54 | $2.56 | $2.67 | $2.37 |
| Growth | 57.3% | -21.8% | -8.7% | 42.3% | -0.9% | -4.1% | 12.7% | 16.4% |
| Diluted EPS [+] | $4.05 | $2.57 | $3.29 | $3.60 | $2.53 | $2.55 | $2.65 | $2.35 |
| Growth | 57.3% | -21.8% | -8.6% | 42.3% | -0.7% | -3.9% | 12.9% | 16.5% |
| |
| Dividends per share [+] | $0.96 | $0.88 | $0.80 | $0.80 | $0.45 | | | |
| Growth | 9.1% | 10.0% | -0.5% | 79.9% | | | | |
| |
| Shares outstanding (basic) [+] | 527.0 | 540.0 | 559.0 | 582.0 | 593.0 | 607.0 | 609.0 | 608.0 |
| Growth | -2.4% | -3.4% | -4.0% | -1.9% | -2.3% | -0.3% | 0.2% | 0.7% |
| Shares outstanding (diluted) [+] | 528.0 | 541.0 | 560.0 | 584.0 | 595.0 | 610.0 | 613.0 | 613.0 |
| Growth | -2.4% | -3.4% | -4.1% | -1.8% | -2.5% | -0.5% | 0.0% | 0.5% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|